Home GlaxoSmithKline: Unfairly Beaten Given Strategic Direction
 

Keywords :   


GlaxoSmithKline: Unfairly Beaten Given Strategic Direction

2015-10-26 12:51:30| Biotech - Topix.net

GlaxoSmithKline PLC is a global pharmaceutical giant that is trading below intrinsic value. The company's real focus is on scale and innovation - providing much of the world with the drugs and medications it needs while containing an expansive list of patent-protected drugs in late stage development.

Tags: direction strategic beaten glaxosmithkline

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
18.05Atlantic Tropical Weather Outlook
18.05Eastern North Pacific Tropical Weather Outlook
18.05Atlantic Tropical Weather Outlook
17.05House Republicans release farm bill draft
17.05House Republicans release farm bill draft
17.05Union forming stalled in US Mercedes-Benz
17.05Johnson & Johnson Acquires Atopic Dermatitis Treatment Biotech Company
17.05Register For Sustainable Cosmetics Summit
More »